Trinity Biotech plc

(NASDAQ:TRIB) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Trinity Biotech PLC is in the business of development, manufacture, and marketing of clinical diagnostic products for clinical laboratory and point of care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Premier, Immublot, EZ, Capita and others. Geographically, it has two segments namely the Americas and Rest of World of which it derives a majority of its revenues from the Americas segment.

Contact Information

Website: www.trinitybiotech.com
Email: kevin.tansley@trinitybiotech.com
Main Phone: +353 12769800
Address: IDA Business Park
Address 2: Bray, Co. Wicklow
City / Town: Dublin
Country: IE

Issuer Information

Exchange: NGS
CEO: Ronan O'Caoimh
Employees: 579
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A